Cellebrite DI Ltd. officer David Gee filed a Form 144 notice on November 10, 2026, disclosing a proposed sale of 653 ordinary shares on approximately November 12, 2026, arising from restricted share unit vesting.

Key Highlights

  • Proposed sale: David Gee, an officer of Cellebrite DI Ltd., intends to sell 653 ordinary shares (par value NIS 0.00001) with an aggregate market value of $8,293.10.
  • Source of shares: The 653 shares were acquired on November 11, 2026, through restricted share units vested under an issuer S-8 registered plan, with compensation as the nature of payment.
  • Sell-to-cover arrangement: According to the filing, the sale is pursuant to "a mandatory, non-discretionary, sell-to-cover arrangement for the purposes of satisfying income tax liabilities incurred upon vesting of restricted share unit awards only."
  • Broker: The proposed sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.
  • Prior three-month sales: Gee sold 230 shares on August 12, 2026 (gross proceeds $3,695.59), 2,198 shares on August 21, 2026 (gross proceeds $24,709.03), and 4,323 shares on August 24, 2026 (gross proceeds $49,111.44).
  • Shares outstanding: The filing reports 251,341,060 ordinary shares outstanding as of the notice date.

Cellebrite Officer Files Notice of Proposed RSU Vesting Sale

Cellebrite DI Ltd. (NASDAQ:CLBT), an Israeli-based issuer with SEC file number 001-40772, is the subject of a Form 144 notice filed November 10, 2026, by David Gee, identified as an officer of the company. The notice covers the proposed sale of 653 ordinary shares on approximately November 12, 2026, with an aggregate market value stated in the filing as $8,293.10. The filing lists the exchange as Nasdaq.

The shares proposed for sale originated from a restricted share unit vesting that occurred on November 11, 2026, under an issuer S-8 registered plan, with Cellebrite DI Ltd. named as the person from whom the securities were acquired. The filing states that the transaction is part of a mandatory, non-discretionary, sell-to-cover arrangement intended solely to satisfy income tax liabilities arising from the RSU vesting event.

In the three months prior to this notice, the filing discloses that Gee sold a combined 6,751 ordinary shares across three transactions: 230 shares on August 12, 2026, for gross proceeds of $3,695.59; 2,198 shares on August 21, 2026, for gross proceeds of $24,709.03; and 4,323 shares on August 24, 2026, for gross proceeds of $49,111.44. The total shares outstanding are reported as 251,341,060.

What Was Disclosed

A Form 144 notice was filed on November 10, 2026, by Cellebrite DI Ltd. officer David Gee, covering the proposed sale of 653 ordinary shares on approximately November 12, 2026, valued at $8,293.10, arising from RSU vesting and attributed to a tax withholding obligation.